Skip to content

144Accepted Jun 22, 8:08 PM ET

Enliven Therapeutics, Inc. 144

ORBIMED CAPITAL LLC

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:08 PM

Jun 22, 2026

Filed

Jun 22, 2026

Documents

1

Size

6.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.